tiprankstipranks
Advertisement
Advertisement

AURA Stock Latest News

Aura Biosciences price target raised to $15 from $13 at Evercore ISI
The FlyAura Biosciences price target raised to $15 from $13 at Evercore ISI
18d ago
AURA
Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating
PremiumRatings
Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating
1M ago
AURA
Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline
PremiumCompany Announcements
Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline
1M ago
8K
AURA
Is AURA a Buy, Before Earnings?
PremiumPre-Earnings
Is AURA a Buy, Before Earnings?
1M ago
AURA
Aura Biosciences Expands Evidence With New Patient-Reported Outcome Study in Eye Cancer
PremiumCompany Announcements
Aura Biosciences Expands Evidence With New Patient-Reported Outcome Study in Eye Cancer
2M ago
AURA
Innovative Approach and Promising Data Drive Buy Rating for Aura Biosciences
PremiumRatingsInnovative Approach and Promising Data Drive Buy Rating for Aura Biosciences
5M ago
AURA
Aura Biosciences re-initiated with an Outperform at Evercore ISI
Premium
The Fly
Aura Biosciences re-initiated with an Outperform at Evercore ISI
5M ago
AURA
Buy Rating on Aura Biosciences Inc. Driven by Promising Pipeline and Strategic Expansion in Ocular Oncology
Premium
Ratings
Buy Rating on Aura Biosciences Inc. Driven by Promising Pipeline and Strategic Expansion in Ocular Oncology
6M ago
AURA
Aura Biosciences Reports Q3 2025 Financial Results
PremiumCompany Announcements
Aura Biosciences Reports Q3 2025 Financial Results
6M ago
AURA
Positive Outlook for Aura Biosciences Inc: Strong Financial Position and Promising Clinical Progress Justify Buy Rating
PremiumRatings
Positive Outlook for Aura Biosciences Inc: Strong Financial Position and Promising Clinical Progress Justify Buy Rating
6M ago
AURA
Aura Biosciences Inc: Strong Buy Rating Backed by Promising Clinical Progress and Strategic Oncology Expansion
PremiumRatings
Aura Biosciences Inc: Strong Buy Rating Backed by Promising Clinical Progress and Strategic Oncology Expansion
6M ago
AURA
Aura Biosciences Reports Q3 2025 Financial Results
PremiumCompany Announcements
Aura Biosciences Reports Q3 2025 Financial Results
6M ago
8K
AURA
Aura Biosciences reports Q3 EPS (40c), consensus (47c)
PremiumThe FlyAura Biosciences reports Q3 EPS (40c), consensus (47c)
6M ago
AURA
Aura Biosciences announces cash to fund operations into 1H of 2027
Premium
The Fly
Aura Biosciences announces cash to fund operations into 1H of 2027
6M ago
AURA
Aura Biosciences Advances Bladder Cancer Treatment with AU-011 Study
Premium
Company Announcements
Aura Biosciences Advances Bladder Cancer Treatment with AU-011 Study
6M ago
AURA
Aura Biosciences Advances Eye Cancer Treatment with Phase 2 Trial Update
PremiumCompany Announcements
Aura Biosciences Advances Eye Cancer Treatment with Phase 2 Trial Update
6M ago
AURA
Aura Biosciences’ Phase 3 Trial: A Potential Game-Changer in Ocular Melanoma Treatment
PremiumCompany Announcements
Aura Biosciences’ Phase 3 Trial: A Potential Game-Changer in Ocular Melanoma Treatment
6M ago
AURA
Optimistic Buy Rating for Aura Biosciences Inc: Promising Pipeline, Strategic Positioning, and Strong Financials
PremiumRatings
Optimistic Buy Rating for Aura Biosciences Inc: Promising Pipeline, Strategic Positioning, and Strong Financials
9M ago
AURA
Aura Biosciences Advances Clinical Trials and Strengthens Finances
PremiumCompany Announcements
Aura Biosciences Advances Clinical Trials and Strengthens Finances
9M ago
AURA
Aura Biosciences Inc: Promising Clinical Developments and Strong Financial Position Support Buy Rating
PremiumRatingsAura Biosciences Inc: Promising Clinical Developments and Strong Financial Position Support Buy Rating
9M ago
AURA
Aura Biosciences Inc’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating
Premium
Ratings
Aura Biosciences Inc’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating
9M ago
AURA
Positive Outlook on Aura Biosciences: Strategic Developments and Promising Trials Drive Buy Rating
Premium
Ratings
Positive Outlook on Aura Biosciences: Strategic Developments and Promising Trials Drive Buy Rating
9M ago
AURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >